- Home
- News
- Articles+
- Aerospace
- Agriculture
- Alternate Dispute Resolution
- Banking and Finance
- Bankruptcy
- Book Review
- Bribery & Corruption
- Commercial Litigation
- Competition Law
- Conference Reports
- Consumer Products
- Contract
- Corporate Governance
- Corporate Law
- Covid-19
- Cryptocurrency
- Cybersecurity
- Data Protection
- Defence
- Digital Economy
- E-commerce
- Employment Law
- Energy and Natural Resources
- Entertainment and Sports Law
- Environmental Law
- FDI
- Food and Beverage
- Health Care
- IBC Diaries
- Insurance Law
- Intellectual Property
- International Law
- Know the Law
- Labour Laws
- Litigation
- Litigation Funding
- Manufacturing
- Mergers & Acquisitions
- NFTs
- Privacy
- Private Equity
- Project Finance
- Real Estate
- Risk and Compliance
- Technology Media and Telecom
- Tributes
- Zoom In
- Take On Board
- In Focus
- Law & Policy and Regulation
- IP & Tech Era
- Viewpoint
- Arbitration & Mediation
- Tax
- Student Corner
- AI
- ESG
- Gaming
- Inclusion & Diversity
- Law Firms
- In-House
- Rankings
- E-Magazine
- Legal Era TV
- Events
- News
- Articles
- Aerospace
- Agriculture
- Alternate Dispute Resolution
- Banking and Finance
- Bankruptcy
- Book Review
- Bribery & Corruption
- Commercial Litigation
- Competition Law
- Conference Reports
- Consumer Products
- Contract
- Corporate Governance
- Corporate Law
- Covid-19
- Cryptocurrency
- Cybersecurity
- Data Protection
- Defence
- Digital Economy
- E-commerce
- Employment Law
- Energy and Natural Resources
- Entertainment and Sports Law
- Environmental Law
- FDI
- Food and Beverage
- Health Care
- IBC Diaries
- Insurance Law
- Intellectual Property
- International Law
- Know the Law
- Labour Laws
- Litigation
- Litigation Funding
- Manufacturing
- Mergers & Acquisitions
- NFTs
- Privacy
- Private Equity
- Project Finance
- Real Estate
- Risk and Compliance
- Technology Media and Telecom
- Tributes
- Zoom In
- Take On Board
- In Focus
- Law & Policy and Regulation
- IP & Tech Era
- Viewpoint
- Arbitration & Mediation
- Tax
- Student Corner
- AI
- ESG
- Gaming
- Inclusion & Diversity
- Law Firms
- In-House
- Rankings
- E-Magazine
- Legal Era TV
- Events
Seth Flaum to boost Life Sciences Corporate Team at Wilson Sonsini
Seth Flaum to boost Life Sciences Corporate Team at Wilson Sonsini
He was working with the pharmaceutical giant Daiichi Sankyo
Wilson Sonsini Goodrich & Rosati has hired Seth Flaum as a partner to boost its East Coast life sciences corporate team.
Flaum worked with Daiichi Sankyo for 16 years and until recently as the executive associate general counsel, IP, and business development. He has significant experience in structuring and negotiating biotechnology and life sciences transactions, including joint ventures, manufacturing, and clinical trial agreements.
Doug Clark, the managing partner at Wilson Sonsini, said the hire reflected the firm's ongoing push to secure lawyers with deal-making experience in the life sciences sector in response to growing client demand.
Clark stated, "The healthy business activity in the US and globally among life sciences companies and investors means that clients are seeking deal-making experience, including expertise with R&D agreements, collaborations, and other sophisticated transactions."
Flaum remarked, "I am excited about the opportunity to continue working with innovative life sciences clients and collaborating with the entire team in New York to help the firm expand its client base in various life sciences markets on the East Coast."
Flaum has worked in several roles across Daiichi's legal department, including as senior legal director for business development between 2013 and 2021. He has previously worked in-house as general counsel of H&H Bagels and as corporate counsel at Slim Fast Foods Company before entering private practice at Ullman Shapiro & Ullman in 2002.
Wilson Sonsini's life sciences practice grew earlier this year when it opened a new outpost in Boulder in a bid to deepen its ties to Colorado's booming tech and life sciences markets.
The firm was ranked as a Band Two life sciences player by Chambers and Partners on its home turf in California, behind top-ranked Latham & Watkins and Cooley.